Company Profiles

driven by the PitchBook Platform

Animalgesic Labs

Animalgesic Labs
2007 FOUNDED
OOB STATUS
1-10 EMPLOYEES
Out of Business LATEST DEAL TYPE
$836k TOTAL AMOUNT RAISED
Description

Developer of a drug delivery system designed to provide treatment to animals. The company's drug delivery system develops a buprenorphine extended-release injectable suspension, enabling vets to control the post-procedural pain in mice and rats.

Formerly Known As
Bamvet Laboratories, Baltimore Animal Medicine
Ownership Status
Out of Business
Financing Status
Formerly VC-Backed
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Pharmaceuticals
Primary Office
1121 Benfield Boulevard
Suite Q
Millersville, MD 21108
United States

+1 (410) 514-5955
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Animalgesic Labs’s full profile, request a free trial.

Animalgesic Labs Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Out of Business 01-Sep-2016 $836k Completed Out of Business
5. Grant 04-Jun-2013 00000 00000 Completed Generating Revenue
4. Early Stage VC 12-Feb-2008 00000 00000 Completed Startup
3. Grant 31-Jan-2008 0000 000.00 Completed Startup
2. Accelerator/Incubator 13-Aug-2007 $95.5k $95.5k Completed Startup
1. Accelerator/Incubator Completed Startup
To view this company’s complete deal history including valuation and funding request access »

Animalgesic Labs Executive Team (2)

Name Title Board
Seat
Contact
Info
David Allen Chief Executive Officer & Co-Founder
Michael Guarnieri Ph.D Chief Scientific Advisor and Co-Founder

Animalgesic Labs Board Members (1)

Name Representing Role Since Contact
Info
Brian Cassell Self Board Member 000 0000